Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Reducing Timelines for Vaccine Potency Testing

Shortening the vaccine development cycle by reducing the need for costly, time-consuming manual analyses of vaccine potency is allowing pharma and biotech companies to increase their throughput. Using this strategy, automation can help to ensure that the most effective vaccines reach the market more rapidly.

By Martin Smith at Synbiosis (March 2010)

Keywords: timelines, vaccine, potency, testing, cycle, market, rapidly, development, bacterial, viral, automated counting technology

    View full article    |    Back to Biopharma section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |